Chemical Peels
Customize your policy alerts
Sign up for regence Policy 12.50 alerts
Get alerted when Policy 12.50 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of epidermal and dermal chemical peels, including the clinical circumstances in which they may be medically necessary, not medically necessary, or cosmetic. It applies to providers submitting chemical peel services under Regence BlueCross BlueShield benefits, subject to applicable contract terms.
No material clinical or coverage changes in this revision.
Chemical Peel Coverage Criteria
Medically necessary
May be considered medically necessary when the applicable condition-specific criteria are met.
Medically necessary chemical peel indications
- Active acne: Epidermal chemical peel with 50–70% alpha hydroxy acids for active acne that has failed to respond to a trial of topical and/or oral antibiotic acne therapy.50–70% alpha hydroxy acids; failed topical and/or oral antibiotic trial
- Numerous premalignant lesions: Dermal chemical peel to treat numerous actinic keratoses or other premalignant skin lesions when treatment of the individual lesions becomes impractical.>10 lesions
Not medically necessary
The following services are considered not medically necessary.
Not medically necessary indications
- First-line active acne treatment: Epidermal chemical peel with 50–70% alpha hydroxy acids as a first-line treatment of active acne.50–70% alpha hydroxy acids; first-line treatment
- Fewer than 10 lesions: Dermal chemical peel to treat fewer than 10 actinic keratoses or other premalignant skin lesions.<10 lesions
Cosmetic
The following services are considered cosmetic.
Cosmetic chemical peel indications
- Epidermal cosmetic use: Epidermal chemical peel that does not meet the active-acne medical-necessity or first-line-treatment criteria, including treatment of photoaged skin, wrinkles, or acne scarring.Does not meet Criterion I or III
- Dermal cosmetic use: Dermal chemical peel that does not meet the actinic-keratosis or premalignant-lesion medical-necessity or not-medically-necessary criteria, including treatment of end-stage acne scarring.Does not meet Criterion II or IV
Epidermal chemical peels that do not meet the applicable active-acne criteria are considered cosmetic. This includes treatment of photoaged skin, wrinkles, or acne scarring.
Dermal chemical peels that do not meet the applicable actinic-keratosis or premalignant-lesion criteria are considered cosmetic. This includes treatment of end-stage acne scarring.
An epidermal chemical peel containing 50–70% alpha hydroxy acids is considered not medically necessary when used as a first-line treatment for active acne.
A dermal chemical peel is considered not medically necessary when used to treat fewer than 10 actinic keratoses or other premalignant skin lesions.
Coding and Clinical Thresholds
| No codes listed |
Provider Documentation and Denial Risks
Document failure of prior acne therapy
For an epidermal chemical peel with 50–70% alpha hydroxy acids to be considered medically necessary for active acne, document that the acne failed to respond to a trial of topical and/or oral antibiotic acne therapy.
- Identify the prior topical and/or oral antibiotic acne therapy trial.
- Document that the active acne failed to respond to the trial.
Confirm medical necessity before submitting
Coverage may be denied or classified as not medically necessary when a 50–70% alpha hydroxy acid epidermal peel is used as first-line treatment for active acne, or when a dermal peel treats fewer than 10 actinic keratoses or other premalignant skin lesions. Peels that do not meet the applicable medical-necessity criteria—including treatment of photoaged skin, wrinkles, acne scarring, or end-stage acne scarring—are considered cosmetic.
- Epidermal active-acne peels: document failure of a trial of topical and/or oral antibiotic acne therapy; first-line use is not medically necessary.
- Dermal peels: the medically necessary pathway applies to numerous (>10) actinic keratoses or other premalignant skin lesions when treating individual lesions is impractical.
- Do not submit cosmetic indications such as photoaged skin, wrinkles, acne scarring, or end-stage acne scarring as medically necessary chemical peel services.
Chemical Peel Background
A chemical peel is the controlled removal of varying layers of the epidermis and superficial dermis using a wounding agent such as phenol or trichloroacetic acid. Epidermal peels affect the epidermis, while dermal peels extend into the dermis.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.